IBDEI1C0 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21526,0)
 ;;=J84.117^^70^921^7
 ;;^UTILITY(U,$J,358.3,21526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21526,1,3,0)
 ;;=3^Desquamative Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,21526,1,4,0)
 ;;=4^J84.117
 ;;^UTILITY(U,$J,358.3,21526,2)
 ;;=^340540
 ;;^UTILITY(U,$J,358.3,21527,0)
 ;;=M32.0^^70^921^8
 ;;^UTILITY(U,$J,358.3,21527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21527,1,3,0)
 ;;=3^Drug-Induced Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,21527,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,21527,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,21528,0)
 ;;=M32.11^^70^921^9
 ;;^UTILITY(U,$J,358.3,21528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21528,1,3,0)
 ;;=3^Endocarditis in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,21528,1,4,0)
 ;;=4^M32.11
 ;;^UTILITY(U,$J,358.3,21528,2)
 ;;=^5011754
 ;;^UTILITY(U,$J,358.3,21529,0)
 ;;=J67.0^^70^921^10
 ;;^UTILITY(U,$J,358.3,21529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21529,1,3,0)
 ;;=3^Farmer's Lung
 ;;^UTILITY(U,$J,358.3,21529,1,4,0)
 ;;=4^J67.0
 ;;^UTILITY(U,$J,358.3,21529,2)
 ;;=^44962
 ;;^UTILITY(U,$J,358.3,21530,0)
 ;;=M32.14^^70^921^11
 ;;^UTILITY(U,$J,358.3,21530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21530,1,3,0)
 ;;=3^Glomerular Disease in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,21530,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,21530,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,21531,0)
 ;;=J67.9^^70^921^12
 ;;^UTILITY(U,$J,358.3,21531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21531,1,3,0)
 ;;=3^Hypersensitivity Pneumonitis d/t Unspec Organic Dust
 ;;^UTILITY(U,$J,358.3,21531,1,4,0)
 ;;=4^J67.9
 ;;^UTILITY(U,$J,358.3,21531,2)
 ;;=^5008280
 ;;^UTILITY(U,$J,358.3,21532,0)
 ;;=J84.113^^70^921^14
 ;;^UTILITY(U,$J,358.3,21532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21532,1,3,0)
 ;;=3^Idiopathic Non-Specific Interstitial Pneumonitis
 ;;^UTILITY(U,$J,358.3,21532,1,4,0)
 ;;=4^J84.113
 ;;^UTILITY(U,$J,358.3,21532,2)
 ;;=^340535
 ;;^UTILITY(U,$J,358.3,21533,0)
 ;;=J84.112^^70^921^15
 ;;^UTILITY(U,$J,358.3,21533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21533,1,3,0)
 ;;=3^Idiopathic Pulmonary Fibrosis
 ;;^UTILITY(U,$J,358.3,21533,1,4,0)
 ;;=4^J84.112
 ;;^UTILITY(U,$J,358.3,21533,2)
 ;;=^340534
 ;;^UTILITY(U,$J,358.3,21534,0)
 ;;=J84.111^^70^921^13
 ;;^UTILITY(U,$J,358.3,21534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21534,1,3,0)
 ;;=3^Idiopathic Interstitial Pneumonia NOS
 ;;^UTILITY(U,$J,358.3,21534,1,4,0)
 ;;=4^J84.111
 ;;^UTILITY(U,$J,358.3,21534,2)
 ;;=^340610
 ;;^UTILITY(U,$J,358.3,21535,0)
 ;;=J84.9^^70^921^18
 ;;^UTILITY(U,$J,358.3,21535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21535,1,3,0)
 ;;=3^Interstitial Pulmonary Disease,Unspec
 ;;^UTILITY(U,$J,358.3,21535,1,4,0)
 ;;=4^J84.9
 ;;^UTILITY(U,$J,358.3,21535,2)
 ;;=^5008304
 ;;^UTILITY(U,$J,358.3,21536,0)
 ;;=M32.13^^70^921^19
 ;;^UTILITY(U,$J,358.3,21536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21536,1,3,0)
 ;;=3^Lung Involvement in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,21536,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,21536,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,21537,0)
 ;;=J84.2^^70^921^20
 ;;^UTILITY(U,$J,358.3,21537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21537,1,3,0)
 ;;=3^Lymphoid Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,21537,1,4,0)
 ;;=4^J84.2
 ;;^UTILITY(U,$J,358.3,21537,2)
 ;;=^5008302
